Circulating Tumor Cells for Glioma
Liquid biopsy has entered clinical applications for several cancers, including metastatic breast, prostate, and colorectal cancer for CTC enumeration and NSCLC for EGFR mutations in ctDNA, and has improved the individualized treatment of many cancers, but relatively little progress has been made in...
Main Authors: | Huikai Zhang, Fanen Yuan, Yangzhi Qi, Baohui Liu, Qianxue Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.607150/full |
Similar Items
-
Characterizing the Genomic Landscape of Brain Glioma With Circulating Tumor DNA From Tumor In Situ Fluid
by: Zhiyuan Sheng, et al.
Published: (2021-03-01) -
Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment
by: Yang Xu, et al.
Published: (2021-10-01) -
Combination of multi-modal MRI radiomics and liquid biopsy technique for preoperatively non-invasive diagnosis of glioma based on deep learning: protocol for a double-center, ambispective, diagnostical observational study
by: Ping Hu, et al.
Published: (2023-05-01) -
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017-11-01) -
Isolation of Circulating Tumor Cells from Glioblastoma Patients by Direct Immunomagnetic Targeting
by: David Lynch, et al.
Published: (2020-05-01)